Bristol-Myers Squibb Co. (BMY) PT Raised to $50 at BofA/Merrill Lynch

October 10, 2019 6:26 AM EDT Send to a Friend

BofA/Merrill Lynch analyst Jason Gerberry ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Bristol-Myers Squibb Co. (BMY) PT Raised to $50 at BofA/Merrill Lynch

Member Login

Free News Feed